Description: This discussion about group Life and group Accident and Health insurance covered over insurance, medical catastrophe coverage, conversion privilege, and the regulatory environment. From TRANSACTIONS OF SOCIETY OF ACTUARIES, 1953 VOL. 5 NO. 11.

Description: This general discussion looks at mortality experience with the advent of CSO tables, annuity premium tax, termination dividends, classes of agents included under Social Security, and conditions affecting companies entering the fields of disability income, accident, health, hospitalization and medical insurance.

Description: Discusses types and methods of analysis of morbidity experience, reserves, and policy form drafting issues.

Description: The last three decades have witnessed an important rise in number of people with diabetes in Asia, especially Type 2 Diabetes. Like no other common condition, numerous innovations are currently entering the healthcare system that will soon have a significant impact on management of the condition. This presentation explores the role played by sensors/wearables, artificial intelligence, new drugs and diabetes apps. We assess the realistic potential of such advancements and give an outlook on medium-term pricing and product development.

Description: This discussion on individual sickness and accident insurance looks at the experience under major medical expense contracts with reference to sales, underwriting, claims and administration. The discussion also reviews the safeguards used for underwriting hospital expense coverage beyond age 65 and loss of time coverage for women.

Description: Discusses considerations taken in determining desirable limits on the amount of group life insurance per life - apart from legislative restrictions, problems presented in the extension of group medical insurance to retired lives, and recent group medical experience.

Description: Critical Illness Insurance is one of the fastest growing insurance products available today. Carriers continue to introduce innovative approaches in second, third, and fourth generation products while refining their pricing, underwriting, and claims adjudication processes. This session will look back at historical trends using Gen Re's longstanding, comprehensive Critical Illness Market Survey, and look forward to potential market changes to occur in the next 18 months.